Summary of Changes s2

SUMMARY OF CHANGES:

INSTRUMENT NOS. 77 to 102 OF 2016

Statements of Principles (SOPs) Nos. 77 to 102 of 2016 were signed by the Chairperson of the Repatriation Medical Authority (the Authority) on 28 October 2016.

The Instruments have been lodged and registered with the Federal Register of Legislation, pursuant to section 15G of the Legislation Act 2003 (Legislation Act). The day of commencement as specified in each of the Statements of Principles is 28 November 2016. In accordance with the Legislation Act, the Office of Parliamentary Counsel must generally deliver a legislative instrument for laying before each House of the Parliament within six sitting days of that House after the instrument is registered with the instrument’s registered explanatory statement. The Instruments and the associated Explanatory Statements registered

with the Federal Register of Legislation are available from: 25T 25TUUhttp://www.legislation.gov.au UU25T25T.

Copies of each Instrument, the associated Explanatory Statement and a list of references relating to each Instrument, are available in accordance with the Veterans' Entitlements Act 1986 (the VEA), on written request from the RMA Secretariat.

The Authority has introduced significant change to the format of the Statements of Principles determined by it under subsections 196B(2) and 196B(3) of the VEA. The changes were introduced to make the relationship between the provisions of the Statements of Principles and the legislative framework for their creation and use clearer and to make them more accessible to users. The 'User Guide to the RMA Statements of Principles' explains the meaning and purpose of each section of the new template. This document is available on the

Authority's website 25T 25Thttp://www.rma.gov.au 25T25T.

For further information contact:

The Registrar Repatriation Medical Authority GPO Box 1014 Brisbane Qld 4001

T +61 7 3815 9404 F +61 7 3815 9412 E [email protected]

4 November 2016

Page 1 of 10 SUMMARY OF CHANGES

Instr. No. Title Date of effect ICD-10-AM Codes REVOCATIONS

77 & 78/2016 analgesic nephropathy 28/11/2016 N14.0

79 & 80/2016 fibromuscular dysplasia 28/11/2016 I77.3

81 & 82/2016 animal envenomation 28/11/2016 T63, X20-X25, X26, X27 or X29, excluding specified and unspecified plants in X26 and X29

83 & 84/2016 schizophrenia 28/11/2016 F20.0-F20.3, F20.5 or F20.9

85 & 86/2016 malignant neoplasm of 28/11/2016 C71 the brain

87 & 88/2016 acquired cataract 28/11/2016 H25, H26.1-H26.9, H28.1 or H28.2

89 & 90/2016 smallpox 28/11/2016 B03

DETERMINATIONS

91 & 92/2016 bruxism 28/11/2016 N/A

93 & 94/2016 umbilical hernia 28/11/2016 K42.0, K42.1 or K42.9

95 & 96/2016 female sexual 28/11/2016 N/A dysfunction

97 & 98/2016 complex regional pain 28/11/2016 N/A syndrome

AMENDMENTS

99 & 100/2016 anxiety disorder 28/11/2016 N/A

101 & 102/2016 panic disorder 28/11/2016 N/A

2 Page 3 of 10 SUMMARY OF CHANGES 77 & analgesic These Instruments result from an investigation notified by the Authority in the Government 78/2016 nephropathy Notices Gazette of 2 October 2015 concerning analgesic nephropathy in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH & BoP SoPs (Instrument Nos. 77 & 78/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'analgesic nephropathy' in subsection 7(2);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(1) concerning 'consuming a total of at least one kilogram of phenacetin';  revising the factor in subsection 9(2) concerning 'consuming an average of at least one gram per day of phenacetin';  new definitions of 'MRCA', 'phenacetin' and 'VEA' in Schedule 1 - Dictionary; and  revising the definition of 'relevant service' in Schedule 1 - Dictionary. The determining of these Instruments finalises the investigation in relation to analgesic nephropathy as advertised in the Government Notices Gazette of 2 October 2015. 79 & fibromuscular These Instruments result from an investigation notified by the Authority in the Government 80/2016 dysplasia Notices Gazette of 2 October 2015 concerning fibromuscular dysplasia in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical- scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH & BoP SoPs (Instrument Nos. 79 & 80/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the reference to 'ICD-10-AM code' in subsection 7(4);  new factors in subsections 9(1) & 9(2) concerning 'smoking';  new definitions of 'pack-years of cigarettes, or the equivalent thereof in other tobacco products', 'MRCA' and 'VEA' in Schedule 1 - Dictionary; and  revising the definition of 'relevant service' in Schedule 1 - Dictionary. The determining of these Instruments finalises the investigation in relation to fibromuscular dysplasia as advertised in the Government Notices Gazette of 2 October 2015. 81 & animal These Instruments result from an investigation notified by the Authority in the Government 82/2016 envenomation Notices Gazette of 2 October 2015 concerning animal envenomation in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH & BoP SoPs (Instrument Nos. 81 & 82/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the ICD-10-AM codes for 'animal envenomation' in subsection 7(3);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(2) concerning 'internal absorption of venom from a venomous animal';  new factor in subsection 9(3) concerning 'internal absorption of venom from a tick of the family Ixodidae';  new definitions of 'MRCA' and 'VEA' in Schedule 1 - Dictionary; and  revising the definitions of 'venomous animal' and 'relevant service' in Schedule 1 - Dictionary. The determining of these Instruments finalises the investigation in relation to animal envenomation as advertised in the Government Notices Gazette of 2 October 2015.

4 SUMMARY OF CHANGES 83 & schizophrenia These Instruments result from an investigation notified by the Authority in the Government 84/2016 Notices Gazette of 2 July 2015 concerning schizophrenia in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH SoP (Instrument No. 83/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'schizophrenia' in subsection 7(2);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(1) concerning 'severe childhood abuse';  new factor in subsection 9(2) concerning 'category 1A stressor';  new factor in subsection 9(3) concerning 'category 1B stressor';  revising the factor in subsection 9(5) concerning 'death of a parent';  revising the factor in subsection 9(6) concerning 'substance use disorder, involving cannabis';  revising the factor in subsection 9(7) concerning 'cannabis';  new factor in subsection 9(8) concerning 'alcohol use disorder or substance use disorder involving a drug or a class of drugs';  revising the factor in subsection 9(9) concerning 'viral meningitis, encephalitis or meningoencephalitis';  revising the factor in subsection 9(10) concerning 'serological evidence of an infection';  revising the factor in subsection 9(11) concerning 'moderate to severe traumatic brain injury';  new factor in subsection 9(12) concerning 'concussion';  revising the factor in subsection 9(17) concerning 'taking a drug or a drug from a class of drugs';  revising the factor in subsection 9(18) concerning 'ceased, reduced or changed antipsychotic drug therapy';  revising the factor in subsection 9(19) concerning 'a clinically significant disorder of mental health';  deleting the factor concerning 'severe childhood abuse', for clinical worsening only;  deleting the factors concerning 'drug dependence or drug abuse' and 'alcohol dependence or alcohol abuse' as these factors are now covered by the factor in subsection 9(19) concerning 'a clinically significant disorder of mental health';  new definitions of 'clinically significant disorder of mental health as specified', 'DSM-5', 'MRCA', 'specified list of infections', 'Specified List 1 of drugs', 'Specified List 2 of drugs' and 'VEA' in Schedule 1 - Dictionary;  revising the definitions of 'category 1A stressor', 'inhalants' and 'relevant service' in Schedule 1 - Dictionary; and  deleting the definitions of 'a clinically significant psychiatric condition', 'a drug or a drug from the class of drugs in specified list 1', 'being infected with Toxoplasma gondii', 'DSM- IV-TR', 'early death of a parent' and 'moderate to severe cerebral trauma'. For BoP SoP (Instrument No. 84/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'schizophrenia' in subsection 7(2);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(1) concerning 'severe childhood abuse';  new factor in subsection 9(2) concerning 'category 1A stressor';  new factor in subsection 9(3) concerning 'category 1B stressor';  revising the factor in subsection 9(5) concerning 'substance use disorder, involving cannabis';  revising the factor in subsection 9(6) concerning 'cannabis';  revising the factor in subsection 9(12) concerning 'taking a drug or a drug from a class of drugs';  revising the factor in subsection 9(13) concerning 'ceased, reduced or changed antipsychotic drug therapy';  revising the factor in subsection 9(14) concerning 'a clinically significant disorder of mental health';  deleting the factor concerning 'death of a parent';

Page 5 of 10 SUMMARY OF CHANGES  deleting the factor concerning 'severe childhood abuse', for clinical worsening only;  deleting the factors concerning 'drug dependence or drug abuse' and 'alcohol dependence or alcohol abuse' as these factors are now covered by the factor in subsection 9(14) concerning 'a clinically significant disorder of mental health';  new definitions of 'clinically significant disorder of mental health as specified', 'DSM-5', 'MRCA', 'Specified List 1 of drugs', 'Specified List 2 of drugs' and 'VEA' in Schedule 1 - Dictionary;  revising the definitions of 'category 1A stressor', 'inhalants' and 'relevant service' in Schedule 1 - Dictionary; and  deleting the definitions of 'a clinically significant psychiatric condition', 'a drug or a drug from the class of drugs in specified list 1', 'DSM-IV-TR', 'early death of a parent' and 'early- onset drug dependence or early-onset drug abuse, involving cannabis'. On 16 June 2016, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instruments and the medical-scientific material considered by the Authority. This letter emphasised the deletion of factors relating to death of a parent (BoP SoP only) and severe childhood abuse, for clinical worsening only (RH & BoP SoPs). The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination. No submissions were received for consideration by the Authority. Minor formatting changes were made to the proposed Instruments following this consultation process. The determining of these Instruments finalises the investigation in relation to schizophrenia as advertised in the Government Notices Gazette of 2 July 2015. 85 & malignant These Instruments result from an investigation notified by the Authority in the Government 86/2016 neoplasm of the Notices Gazette of 1 September 2015 concerning malignant neoplasm of the brain in accordance brain with section 196G of the VEA. The investigation involved an examination of the sound medical- scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH SoP (Instrument No. 85/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'malignant neoplasm of the brain' in subsection 7(2);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(2) concerning 'human immunodeficiency virus';  deleting the factor concerning 'an organ transplant from a donor with malignant neoplasm of the brain';  new definitions of 'MRCA' and 'VEA' in Schedule 1 - Dictionary;  revising the definitions of 'neuroepithelial tumour' and 'relevant service' in Schedule 1 - Dictionary; and  deleting the definition of 'being infected with human immunodeficiency virus'. For BoP SoP (Instrument No. 86/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'malignant neoplasm of the brain' in subsection 7(2);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(1) concerning 'ionising radiation';  new definitions of 'MRCA' and 'VEA' in Schedule 1 - Dictionary; and  revising the definitions of 'neuroepithelial tumour' and 'relevant service' in Schedule 1 - Dictionary. On 16 June 2016, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instruments and the medical-scientific material considered by the Authority. This letter emphasised the deletion of a factor relating to an organ transplant from a donor with malignant neoplasm of the brain (RH SoP only). The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination. No submissions were received for consideration by the Authority. No changes were made to the proposed Instruments following this consultation process. The determining of these Instruments finalises the investigation in relation to malignant neoplasm of the brain as advertised in the Government Notices Gazette of 1 September

6 SUMMARY OF CHANGES 2015. 87 & acquired These Instruments result from an investigation notified by the Authority in the Government 88/2016 cataract Notices Gazette of 2 October 2015 concerning acquired cataract in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH SoP (Instrument No. 87/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'acquired cataract' in subsection 7(2);  revising ICD-10-AM codes for 'acquired cataract' in subsection 7(3);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factors in subsections 9(1) & 9(15) concerning 'sunlight exposure';  revising the factors in subsections 9(2) & 9(16) concerning 'smoking';  new factors 9(9) & 9(23) concerning 'being treated with a selective serotonin reuptake inhibitor or a serotonin and noradrenaline (norepinephrine) reuptake inhibitor';  new factors 9(10) & 9(24) concerning 'taking an antimalarial agent';  new factors in subsections 9(13) & 9(27) concerning 'being overweight or obese';  new factors in subsections 9(14) & 9(28) concerning 'hypoparathyroidism', for cortical and subcapsular cataract only;  deleting the factors concerning 'hypocalcaemia' as acquired cataract is only due to hypocalcaemia which is caused by hypoparathyroidism, and new factors concerning 'hypoparathyroidism' are included in subsections 9(14) & 9(28);  deleting the factors concerning 'glaucoma';  new definitions of 'being overweight or obese', 'BMI', 'MRCA' and 'VEA' in Schedule 1 - Dictionary;  revising the definitions of 'being treated with a drug as specified', being treated with an oral, topical or inhalational corticosteroid as specified', 'pack-years of cigarettes, or the equivalent thereof in other tobacco products', 'relevant service' and 'severe thermal or chemical burn' in Schedule 1 - Dictionary; and  deleting the definitions of 'glaucoma', 'hypocalcaemia' and 'the unprotected eye'. For BoP SoP (Instrument No. 88/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'acquired cataract' in subsection 7(2);  revising ICD-10-AM codes for 'acquired cataract' in subsection 7(3);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factors in subsections 9(1) & 9(14) concerning 'sunlight exposure';  revising the factors in subsections 9(2) & 9(15) concerning 'smoking';  new factors 9(9) & 9(22) concerning 'being treated with a selective serotonin reuptake inhibitor or a serotonin and noradrenaline (norepinephrine) reuptake inhibitor';  new factors in subsection 9(12) & 9(25) concerning 'being overweight or obese';  new factors in subsections 9(13) & 9(26) concerning 'hypoparathyroidism', for cortical and subcapsular cataract only;  deleting the factors concerning 'hypocalcaemia' as acquired cataract is only due to hypocalcaemia which is caused by hypoparathyroidism, and new factors concerning 'hypoparathyroidism' are included in subsections 9(13) & 9(26);  deleting the factors concerning 'glaucoma';  new definitions of 'being overweight or obese', 'BMI', 'MRCA' and 'VEA' in Schedule 1 - Dictionary;  revising the definitions of 'being treated with a drug as specified', being treated with an oral, topical or inhalational corticosteroid as specified', 'pack-years of cigarettes, or the equivalent thereof in other tobacco products', 'relevant service' and 'severe thermal or chemical burn' in Schedule 1 - Dictionary; and  deleting the definitions of 'glaucoma', 'hypocalcaemia' and 'the unprotected eye'. On 16 June 2016, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instruments and the medical-scientific material considered by the Authority. This letter emphasised the deletion of factors relating to glaucoma.

Page 7 of 10 SUMMARY OF CHANGES The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination. No submissions were received for consideration by the Authority. Changes made to the proposed Instruments following this consultation process include the inclusion of additional drugs as risk factors for the clinical onset and clinical worsening of acquired cataract. The determining of these Instruments finalises the investigation in relation to acquired cataract as advertised in the Government Notices Gazette of 2 October 2015. 89 & smallpox These Instruments result from an investigation notified by the Authority in the Government 90/2016 Notices Gazette of 2 October 2015 concerning smallpox in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered. The contents of these Instruments are in similar terms as the revoked Instruments. Comparing these Instruments and the revoked Instruments, the differences include: For RH & BoP SoPs (Instrument Nos. 89 & 90/2016)  adopting the latest revised Instrument format, which commenced in 2015;  specifying a day of commencement for the Instrument in section 2;  revising the definition of 'smallpox' in subsection 7(2);  revising the reference to 'ICD-10-AM code' in subsection 7(4);  revising the factor in subsection 9(1) concerning 'being exposed to the variola virus';  new factor in subsection 9(2) concerning 'being pregnant', for death from smallpox only;  deleting the factor concerning 'being in an immunocompromised state';  new definitions of 'MRCA' and 'VEA' in Schedule 1 - Dictionary;  revising the definitions of 'being exposed to the variola virus' and 'relevant service' in Schedule 1 - Dictionary; and  deleting the definition of 'an immunocompromised state'. On 16 June 2016, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instruments and the medical-scientific material considered by the Authority. This letter emphasised the deletion of factors relating to being in an immunocompromised state. The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination. No submissions were received for consideration by the Authority. Minor typographical changes were made to the proposed Instruments following this consultation process. The determining of these Instruments finalises the investigation in relation to smallpox as advertised in the Government Notices Gazette of 2 October 2015. 91 & bruxism New Condition 92/2016 The determining of these new Instruments finalises the investigation in relation to bruxism as advertised in the Government Notices Gazette of 9 December 2015. 93 & umbilical hernia New Condition 94/2016 The determining of these new Instruments finalises the investigation in relation to umbilical hernia as advertised in the Government Notices Gazette of 9 December 2015. 95 & female sexual New Condition 96/2016 dysfunction The determining of these new Instruments finalises the investigation in relation to female sexual dysfunctions as advertised in the Government Notices Gazette of 9 December 2015. 97 & complex New Conditions 98/2016 regional pain The determining of these new Instruments finalises the investigation in relation to syndrome complex regional pain syndrome as advertised in the Government Notices Gazette of 15 March 2016. 99 & anxiety disorder Amendments 100/2016 These instruments amend Statements of Principles Nos. 102 & 103 of 2014 concerning anxiety disorder by: RH Amendment SoP (Instrument No. 99/2016)  replacing the definition of 'anxiety disorder' in clause 3(b);  deleting clauses 3(c) and 3(d);  inserting new factors (ba)(i) & (qa) in clause 6 concerning 'taking a drug or a drug from a class of drugs';

8 SUMMARY OF CHANGES  inserting new factors (ba)(ii) & (qb) in clause 6 concerning 'using or inhaling a substance';  inserting new factor (ba)(iii) in clause 6 concerning 'taking a drug which results in the development of anxiety symptoms or panic attacks';  inserting new factors (ba)(iv) & (qd) in clause 6 concerning 'ingesting or inhaling a chemical or a substance';  inserting new factors (ba)(v) & (qe) in clause 6 concerning 'having ceased or reduced therapeutic or illicit drug use or other substance use';  inserting new factors (ba)(vi) & (qf) in clause 6 concerning 'periodic, heavy alcohol consumption';  inserting new factors (ba)(vii) & (qg) in clause 6 concerning 'an alcohol use disorder or a substance use disorder';  inserting new factors (ba)(viii) & (qh) in clause 6 concerning 'smoking';  inserting new factors (ba)(ix) & q(i) in clause 6 concerning 'an episode of acute cholinergic poisoning';  inserting new factor (ba)(x) in clause 6 concerning 'taking at least 200 milligrams of caffeine from beverages, drugs or foods', for persons without a regular caffeine habit, for clinical onset only;  inserting new factor (ba)(xi) in clause 6 concerning 'taking at least 800 milligrams of caffeine from beverages, drugs or foods' for persons with a regular caffeine habit, for clinical onset only;  inserting new factor (qc) in clause 6 concerning 'taking a drug which results in the re- development or worsening of anxiety symptoms or panic attacks', for clinical worsening only;  inserting new factor (qj) in clause 6 concerning 'taking at least 400 milligrams of caffeine from beverages, drugs or foods' for clinical worsening only;  inserting the definitions of 'acute cholinergic poisoning', 'alcohol', 'cigarettes per day, or the equivalent thereof in other tobacco products', 'inhalants', 'intoxication', 'organic solvents', 'organophosphorus ester', 'periodic, heavy alcohol consumption', 'regular caffeine habit', 'specified list of drugs' and 'specified list of substances' in clause 9 in alphabetical order; and  deleting the definition of 'ICD-10-AM code' in clause 9. BoP Amendment SoP (Instrument No. 100/2016)  replacing the definition of 'anxiety disorder' in clause 3(b);  deleting clauses 3(c) and 3(d);  inserting new factors (ba)(i) & (na) in clause 6 concerning 'taking a drug or a drug from a class of drugs';  inserting new factors (ba)(ii) & (nb) in clause 6 concerning 'using or inhaling a substance';  inserting new factor (ba)(iii) in clause 6 concerning 'taking a drug which results in the development of anxiety symptoms or panic attacks';  inserting new factors (ba)(iv) & (nd) in clause 6 concerning 'ingesting or inhaling a chemical or a substance';  inserting new factors (ba)(v) & (ne) in clause 6 concerning 'having ceased or reduced therapeutic or illicit drug use or other substance use';  inserting new factors (ba)(vi) & (nf) in clause 6 concerning 'periodic, heavy alcohol consumption';  inserting new factors (ba)(vii) & (ng) in clause 6 concerning 'an alcohol use disorder or a substance use disorder';  inserting new factors (ba)(viii) & (nh) in clause 6 concerning 'smoking';  inserting new factor (ba)(ix) in clause 6 concerning 'taking at least 200 milligrams of caffeine from beverages, drugs or foods', for persons without a regular caffeine habit, for clinical onset only;  inserting new factor (ba)(x) in clause 6 concerning 'taking at least 800 milligrams of caffeine from beverages, drugs or foods' for persons with a regular caffeine habit, for clinical onset only;  inserting new factor (nc) in clause 6 concerning 'taking a drug which results in the re- development or worsening of anxiety symptoms or panic attacks', for clinical worsening only;  inserting new factor (ni) in clause 6 concerning 'taking at least 400 milligrams of caffeine from beverages, drugs or foods' for clinical worsening only;  inserting the definitions of 'alcohol', 'cigarettes per day, or the equivalent thereof in other tobacco products', 'inhalants', 'intoxication', 'organic solvents', 'periodic, heavy alcohol consumption', 'regular caffeine habit', 'specified list of drugs' and 'specified list of substances'

Page 9 of 10 SUMMARY OF CHANGES in clause 9 in alphabetical order; and  deleting the definition of 'ICD-10-AM code' in clause 9. The determining of these Instruments finalises the investigation in relation to anxiety disorder as advertised in the Government Notices Gazette of 30 June 2015. 101 & panic disorder Amendments 102/2016 These instruments amend Statements of Principles Nos. 68 & 69 of 2009 concerning panic disorder by: RH Amendment SoP (Instrument No. 101/2016)  replacing the definition of 'panic disorder' in clause 3(b);  replacing factors (e) & (l) in clause 6 concerning 'a clinically significant disorder of mental health';  replacing the definitions of 'ICD-10-AM code' and 'relevant service';  inserting the definitions of 'a clinically significant disorder of mental health from Specified List 1', 'a clinically significant disorder of mental health from Specified List 2' and 'DSM-5' in clause 9 in alphabetical order; and  deleting the definitions of 'a clinically significant psychiatric condition from specified list 1', 'a clinically significant psychiatric condition from specified list 2', 'DSM-IV-TR', 'obsessive- compulsive disorder', 'panic attack', 'phobic anxiety' and 'substance-induced anxiety disorder' in clause 9. BoP Amendment SoP (Instrument No. 102/2016)  replacing the definition of 'panic disorder' in clause 3(b);  replacing factors (e) & (k) in clause 6 concerning 'a clinically significant disorder of mental health';  replacing the definitions of 'ICD-10-AM code' and 'relevant service';  inserting the definitions of 'a clinically significant disorder of mental health from Specified List 1', 'a clinically significant disorder of mental health from Specified List 2' and 'DSM-5' in clause 9 in alphabetical order; and  deleting the definitions of 'a clinically significant psychiatric condition from specified list 1', 'a clinically significant psychiatric condition from specified list 2', 'DSM-IV-TR', 'obsessive- compulsive disorder', 'panic attack', 'phobic anxiety' and 'substance-induced anxiety disorder' in clause 9. The determining of these Instruments finalises the investigation in relation to panic disorder as advertised in the Government Notices Gazette of 30 June 2015.